Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BNTX | ALNY | BIIB | ||
| Company | Biontech Se ADR | Alnylam Pharmaceuticals | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 102.38 | 247.46 | 157.17 | ||
| High | 106.99 | 250.71 | 158.00 | ||
| Low | 101.26 | 246.26 | 154.74 | ||
| Last | 106.31 | 249.83 | 157.55 | ||
| Change | +4.17 | +1.04 | +1.55 | ||
| % Change | +4.08% | +0.42% | +0.99% | ||
| Volume | 364,776 | 232,264 | 619,362 | ||
| 20-Day Average Volume | 1,045,826 | 955,935 | 1,707,835 | ||
| Previous Close | 102.14 | 248.79 | 156.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.36 | 265.42 | 170.43 | ||
| 20-Day Raw Stochastic | 52.17% | 31.24% | 10.66% | ||
| 20-Day Relative Strength | 47.04% | 41.83% | 25.57% | ||
| Weighted Alpha | -6.13 | +23.68 | -37.91 | ||
| Today's Opinion | 40% Buy | 8% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.96% since 11/14/24 | -3.14% since 11/14/24 | -4.64% since 11/14/24 | ||
| Low | 94.31 on 11/15/24 | 229.85 on 11/18/24 | 153.62 on 11/20/24 | ||
| High | 108.01 on 11/19/24 | 254.17 on 11/15/24 | 166.34 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -5.37% since 10/21/24 | -14.45% since 10/21/24 | -14.84% since 10/21/24 | ||
| Low | 94.31 on 11/15/24 | 229.85 on 11/18/24 | 153.62 on 11/20/24 | ||
| High | 115.93 on 11/14/24 | 301.05 on 10/24/24 | 187.58 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | +18.65% since 08/21/24 | -10.52% since 08/21/24 | -23.74% since 08/21/24 | ||
| Low | 85.00 on 08/28/24 | 229.85 on 11/18/24 | 153.62 on 11/20/24 | ||
| High | 131.49 on 09/17/24 | 304.39 on 10/17/24 | 206.76 on 08/22/24 | ||
| 6-Month | |||||
| %Chg | +14.68% since 05/21/24 | +66.96% since 05/21/24 | -30.94% since 05/21/24 | ||
| Low | 76.53 on 08/05/24 | 146.79 on 05/30/24 | 153.62 on 11/20/24 | ||
| High | 131.49 on 09/17/24 | 304.39 on 10/17/24 | 238.00 on 07/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,487,044 | 32,089,182 | 22,732,162 | ||
| Shares Outstanding, K | 239,740 | 128,981 | 145,719 | ||
| Annual Sales | 4,133,300,000 | 1,828,290,000 | 9,835,600,000 | ||
| Annual Net Income | 1,006,860,000 | -440,240,000 | 1,161,100,000 | ||
| Last Quarter Sales | 1,368,780,000 | 500,920,000 | 2,465,800,000 | ||
| Last Quarter Net Income | 217,830,000 | -111,570,000 | 388,500,000 | ||
| 60-Month Beta | 0.26 | 0.39 | -0.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 11/04/24 | -0.50 on 10/31/24 | 4.08 on 10/30/24 | ||
| Latest Earnings Date | 11/04/24 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | 3.084 on 06/02/22 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/02/22 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 9.73 | ||